Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
---|
07/01/2009 | EP2074103A1 6-phenylpyrimidinones as pim modulators |
07/01/2009 | EP2074093A2 Matrix metalloproteinase inhibitors |
07/01/2009 | EP2074089A2 Organic compounds |
07/01/2009 | EP2074086A1 Biphenyl sulfonyl and phenyl-heteroaryl sulfonyl modulators of the histamine h3-receptor useful for the treatment of disorders related thereto |
07/01/2009 | EP2074084A1 Compounds which modulate the cb2 receptor |
07/01/2009 | EP1861365B1 N-sulphonylpyrroles and their use as histone deacetylase inhibitors |
07/01/2009 | EP1784393B1 Quinazolines useful as modulators of ion channels |
07/01/2009 | EP1776339B1 3-(((4-phenyl)-piperazin-1-yl)-alkyl)-3-alkyl-1,3-dihydro-2h-indol-2-one derivatives and related compounds for the treatment of central nervous system disorders |
07/01/2009 | EP1691810A4 Substituted piperazines |
07/01/2009 | EP1686999B1 Pyrazole derivatives as inhibitors of receptor tyrosine kinases |
07/01/2009 | EP1576159B1 The gene cluster involved in safracin biosynthesis and its uses for genetic engineering |
07/01/2009 | EP1423362B1 New mandelic acid derivative and its use as thrombin inhibitor |
07/01/2009 | CN101472916A Chemical compounds |
07/01/2009 | CN101472915A Indazole compounds and methods for inhibition of CDC7 |
07/01/2009 | CN101468985A 5-(3-aromatic heterocyclic substituted phenyl) tetrazole compounds and anti-HIV/AIDS use thereof |
07/01/2009 | CN101468965A Biaryl substituted 6-membered heterocyles as sodium channel blockers |
07/01/2009 | CN100506818C Imidazole-5-carboxylic acid derivative, its production and use |
07/01/2009 | CN100506817C Ortho-heterocyclic substituted aryl amides for controlling invertebrate pests |
07/01/2009 | CN100506801C Inhibitors of glycogen synthase kinase 3 |
07/01/2009 | CN100506792C Substituted N-arylheterocycles, method for production and use thereof as medicaments |
07/01/2009 | CN100506776C NK1 antagonists |
06/30/2009 | US7553972 Benzamide inhibitors of the P2X7 receptor |
06/30/2009 | US7553877 Use of 2-hydroxy-1,2,3,4,4a,9,10,10a-octahydrophenanthrene compounds glucocorticoid receptor agonists to treat certain inflammatory conditions such as arthritis, asthma |
06/30/2009 | US7553861 Type-2 diabetes |
06/30/2009 | US7553840 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use |
06/30/2009 | US7553838 Mitotic kinesin inhibitors |
06/30/2009 | US7553798 Heterocyclic carboxamides with microbiocidal activity |
06/30/2009 | US7553604 Lower thermal decomposition temperatures; high speed laser recording; light absorbers in optical filter light absorbers |
06/25/2009 | WO2009079624A1 4-imidazolidinones as kv1.5 potassium channel inhibitors |
06/25/2009 | WO2009079225A1 Cyclopropyl amine derivatives |
06/25/2009 | WO2009077858A2 Hemioxalate salt of eletriptan |
06/25/2009 | WO2009077728A1 Indoles and their therapeutic use |
06/25/2009 | WO2009077680A1 Quinazolinedione derivatives, preparation thereof and therapeutic uses thereof |
06/25/2009 | WO2009077608A1 2 -aminopyrimidine derivatives as histamine h4 antagonists |
06/25/2009 | WO2009077533A1 Fluoroalkyl substituted benzimidazole cannabinoid agonists |
06/25/2009 | WO2009077371A1 Tetrazole-substituted arylamide derivatives and their use as p2x3 and/or p2x2/3 purinergic receptor antagonists |
06/25/2009 | WO2009077366A1 Triazole-substituted arylamide derivatives and their use as p2x3 and /or p2x2/3 purinergic receptor antagonists |
06/25/2009 | WO2009077365A1 Novel imidazole-substituted arylamides |
06/25/2009 | WO2009077059A1 Synthesis of biguanidines and triazines, and biguanidino-aluminium complexes as intermediates |
06/25/2009 | WO2009061761A3 Fungicidal heterocyclic amines |
06/25/2009 | US20090163708 Process for preparing mesylate salts of il-12 inhibitory compounds |
06/25/2009 | US20090163569 Process for the production of amides |
06/25/2009 | US20090163560 5-(3-(2-(4-(1-Hydroxyhexyl)phenyl)-3-oxopyrazolidin-1-yl)propyl)thiophene-2-carboxylic acid; bioisosteres; vision defects; glaucoma; hypotensive agents; ocular hypertension; kits |
06/25/2009 | US20090163518 Novel Compounds |
06/25/2009 | US20090163516 Carboxamides for controlling undesired micro-organisms in plant protection |
06/25/2009 | US20090163508 Amide compound |
06/25/2009 | US20090163506 Urea-compounds active as vanilloid receptor antagonists for the treatment of pain |
06/25/2009 | US20090163505 Amino-heteroaryl-containing prokineticin 1 receptor antagonists |
06/25/2009 | US20090163503 Substituted pyrrolo-pyrazole derivatives active as kinase inhibitors |
06/25/2009 | US20090163497 Compounds Useful as Antagonists of CCR2 |
06/25/2009 | US20090163494 Protein kinase inhibitors |
06/25/2009 | US20090163485 Heteroaryl derivatives as orexin receptor antagonists |
06/25/2009 | US20090163472 Mineralocorticoid receptor antagonists and methods of use |
06/25/2009 | US20090163467 New compounds |
06/25/2009 | US20090160326 Organic electroluminescence material and element using the same |
06/25/2009 | US20090160315 Organic electroluminescence material and element using the same |
06/25/2009 | DE102007062550A1 Perhydrochinoxalin-Derivate Perhydroquinoxaline derivatives |
06/25/2009 | DE102007061963A1 Pyridazinonderivate Pyridazinone derivatives |
06/25/2009 | DE102007061766A1 New 4-(4-cyano-2-thioaryl)-dihydro-pyrimidinone compounds are human neutrophil elastase inhibitor, useful for the treatment or prevention of e.g. pulmonary arterial hypertonia, acute lung injury and diseases of the cardiovascular system |
06/25/2009 | CA2709186A1 4-imidazolidinones as kv1.5 potassium channel inhibitors |
06/25/2009 | CA2709081A1 Cyclopropyl amine derivatives |
06/25/2009 | CA2708791A1 Novel imidazole-substituted arylamides |
06/25/2009 | CA2708228A1 Tetrazole-substituted arylamide derivatives and their use as p2x3 and/or p2x2/3 purinergic receptor antagonists |
06/25/2009 | CA2707785A1 Indoles and their therapeutic use |
06/25/2009 | CA2707422A1 Triazole-substituted arylamide derivatives and their use as p2x3 and /or p2x2/3 purinergic receptor antagonists |
06/25/2009 | CA2701150A1 Quinazolinedione derivatives, preparation thereof and therapeutic uses thereof |
06/24/2009 | EP2072510A1 Crystalline form of azelastine |
06/24/2009 | EP1844004B1 Quinazoline derivates as antiviral agents |
06/24/2009 | EP1445258B1 Activator for peroxisome proliferator-activated receptor delta |
06/24/2009 | EP1339709B1 Farnesyl transferase inhibiting benzoheterocyclic derivatives |
06/24/2009 | CN101466703A Heterocyclic GABA alpha subtype selective receptor modulators |
06/24/2009 | CN100503601C Process of preparing troipisetron |
06/24/2009 | CN100503600C Pesticidal heterocycles |
06/24/2009 | CN100503599C Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
06/24/2009 | CN100503580C Irreversible inhibitor of tyrosine kinase |
06/24/2009 | CN100503579C Process for producing substituted aniline compound |
06/24/2009 | CN100503566C Inhibitors of cytosolic phospholipase A2 |
06/23/2009 | US7550603 1H-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position are potent PARP inhibitors |
06/23/2009 | US7550597 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
06/23/2009 | US7550590 Such as 2-[2-(3-Amino-piperidin-1-yl)4-oxo-4H-quinazolin-3-ylmethyl]-benzonitrile; type 2 diabetes mellitus, diabetic dislipidemia, impaired glucose tolerance |
06/23/2009 | US7550494 Small molecules useful in the treatment of inflammatory disease |
06/23/2009 | US7550487 Factor Xa inhibitors; anticoagulants; thrombotic disorders; (3R,4R)-3-(4-Chloro-phenylcarbamoyl)-4-[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-pyrrolidine-1-carboxylic acid propyl ester for example |
06/23/2009 | US7550484 Elevate the progenitor and/or stem cell population in peripheral blood or bone marrow; treatment of HIV, inflammatory condition like rheumatoid arthritis, tumor, asthma; 4-(3,3''-Dimethyl-3',4',5',6'-tetrahydro-2'H-cis-[2,2';6',2'']terpyridin-1'-yl-butylamine |
06/23/2009 | US7550473 Pyrimidine derivatives useful as inhibitors of PKC-theta |
06/23/2009 | US7550461 Benzofuran and benzothiophene compounds useful in treating cytokine mediated diseases |
06/23/2009 | US7550460 2,4-pyrimidinediamine compounds and their uses |
06/23/2009 | US7550454 Analogs of clozapine; use with other neuropsychiatric agents; depression, anxiety, bipolar disorder, psychoses secondary to Alzheimer's or Huntington's disease; e.g. 2,7-Dichloro-11-(piperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine |
06/23/2009 | CA2504735C Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
06/23/2009 | CA2449874C New indole derivatives with 5-ht6 receptor affinity |
06/23/2009 | CA2405937C Methylation of indole compounds using dimethyl carbonate |
06/23/2009 | CA2384354C Pyrimidine derivatives and herbicides containing them |
06/23/2009 | CA2245080C Process for the preparation of heteroarylcarboxylic amides and esters |
06/18/2009 | WO2009076404A1 Carboxamide compounds and their use as antagonists of the chemokine ccr2 receptor |
06/18/2009 | WO2009076288A1 Dual-acting benzoimidazole derivative and their use as antihypertensive agents |
06/18/2009 | WO2009076200A2 Solid forms of 1-ethyl-3-(5-(5-fluoropyridin-3-yl)-7-(pyrimidin-2-yl)-1h-benzo[d]imidazol-2-yl)urea |
06/18/2009 | WO2009076166A2 Oximyl hcv serine protease inhibitors |
06/18/2009 | WO2009075960A1 Ccr5 antagonists as therapeutic agents |
06/18/2009 | WO2009075691A1 Cb-1 modulating compounds and their use |
06/18/2009 | WO2009075277A1 4-aminopyrimidine derivative and medicinal composition containing the compound |
06/18/2009 | WO2009074997A2 A novel process for the preparation of crystalline magnesium salt of (s)-omeprazole di hydrate |